UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Accurate Wealth Management LLC

Accurate Wealth Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 194.7% in the fourth quarter, Holdings Channel reports. The fund owned 5,125 shares of the healthcare conglomerate’s stock after buying an additional 3,386 shares during the period. UnitedHealth Group accounts for approximately 0.9% of Accurate Wealth Management LLC’s investment portfolio, making the stock its 16th largest holding. Accurate Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,491,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also made changes to their positions in UNH. CoreCap Advisors LLC grew its stake in shares of UnitedHealth Group by 0.5% during the second quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate’s stock valued at $2,166,000 after acquiring an additional 19 shares in the last quarter. Elgethun Capital Management grew its stake in shares of UnitedHealth Group by 0.3% during the second quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate’s stock valued at $3,369,000 after acquiring an additional 19 shares in the last quarter. Hollencrest Capital Management grew its stake in shares of UnitedHealth Group by 0.8% during the third quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate’s stock valued at $1,180,000 after acquiring an additional 19 shares in the last quarter. Smith Salley & Associates grew its stake in shares of UnitedHealth Group by 0.7% during the third quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate’s stock valued at $1,451,000 after acquiring an additional 19 shares in the last quarter. Finally, MFA Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 4.8% during the third quarter. MFA Wealth Advisors LLC now owns 414 shares of the healthcare conglomerate’s stock valued at $209,000 after acquiring an additional 19 shares in the last quarter. 86.31% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH traded down $2.52 during mid-day trading on Friday, reaching $469.50. 5,289,996 shares of the company’s stock traded hands, compared to its average volume of 3,713,042. UnitedHealth Group Incorporated has a 12 month low of $449.70 and a 12 month high of $558.10. The stock has a market capitalization of $437.97 billion, a P/E ratio of 22.16, a price-to-earnings-growth ratio of 1.30 and a beta of 0.69. The business’s 50-day moving average price is $483.26 and its 200-day moving average price is $510.78. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.77 and a current ratio of 0.77.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, topping the consensus estimate of $5.17 by $0.17. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The firm had revenue of $82.79 billion for the quarter, compared to analysts’ expectations of $82.53 billion. During the same quarter in the previous year, the company earned $4.48 earnings per share. The firm’s quarterly revenue was up 12.3% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 21st. Investors of record on Monday, March 13th will be issued a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, March 10th. This represents a $6.60 annualized dividend and a yield of 1.41%. UnitedHealth Group’s payout ratio is 31.15%.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Stephens reiterated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Tuesday, February 28th. Raymond James downgraded UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price target for the company. in a research note on Monday, November 21st. Morgan Stanley reiterated an “overweight” rating and issued a $587.00 price target on shares of UnitedHealth Group in a research note on Wednesday, November 23rd. Credit Suisse Group lifted their price target on UnitedHealth Group from $590.00 to $610.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 7th. Finally, Loop Capital raised their target price on shares of UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday, January 17th. Three research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $599.68.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.